Who invested in Stramsen Biotech?
Stramsen Biotech's investors include The Global Emerging Markets Gem.
United States · Series B startup
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2025, from 1 source
Stramsen Biotech's investors include The Global Emerging Markets Gem.
Stramsen Biotech has raised $25M across 1 round since 2025.
Stramsen Biotech's most recent round was a Series B of $25M in Apr 2025.
Its most recent round, $25M in Apr 2025, is also its largest on record.
Stramsen Biotech's first round on record, in Apr 2025, was backed by The Global Emerging Markets Gem.
Stramsen Biotech's latest named round is a Series B, in Apr 2025.
Stramsen Biotech is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.